Removal of gadolinium by peritoneal dialysis.

Murashima, M; Drott, H R; Carlow, D; Shaw, L M; Milone, M; Bachman, M; Tsai, D E; Yang, S-L; Bloom, R D

Murashima, M; Drott, H R; Carlow, D; Shaw, L M; Milone, M; Bachman, M; Tsai, D E; Yang, S-L; Bloom, R D.

Affiliation

Murashima M; Renal Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.

Clin Nephrol ; 69(5): 368-72, 2008 May.

Article in En | MEDLINE | ID: mdl-18538100

Subject(s)

Contrast Media/pharmacokinetics; Gadolinium/pharmacokinetics; Kidney Failure, Chronic/metabolism; Peritoneal Dialysis; Contrast Media/adverse effects; Fibrosis; Gadolinium/adverse effects; Gadolinium DTPA/adverse effects; Gadolinium DTPA/pharmacokinetics; Humans; Kidney Failure, Chronic/complications; Lymphoma/complications; Lymphoma/diagnosis; Lymphoma/drug therapy; Magnetic Resonance Imaging; Male; Middle Aged; Skin Diseases/chemically induced; Skin Diseases/prevention & control

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peritoneal Dialysis / Contrast Media / Gadolinium / Kidney Failure, Chronic Type of study: Diagnostic_studies Limits: Humans / Male / Middle aged Language: En Journal: Clin Nephrol Year: 2008 Document type: Article Affiliation country: United States Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links